An Ungovernable Foe: Science and Policy Innovation in the U.S. National Cancer Institute
Winner, 2024 Choice Outstanding Academic Title

In American politics, medical innovation is often considered the domain of the private sector. Yet some of the most significant scientific and health breakthroughs of the past century have emerged from government research institutes. The U.S. National Cancer Institute (NCI) is tasked with both understanding and eradicating cancer—and its researchers have developed a surprising expertise in virus research and vaccine development.

An Ungovernable Foe examines seventy years of federally funded scientific breakthroughs in the laboratories of the NCI to shed new light on how bureaucratic organizations nurture innovation. Natalie B. Aviles analyzes research and policy efforts around the search for a viral cause of leukemia in the 1960s, the discovery of HIV and the development of AIDS drugs in the 1980s, and the invention of the HPV vaccine in the 1990s. She argues that the NCI transformed generations of researchers into innovative public servants who have learned to balance their scientific and bureaucratic missions. These “scientist-bureaucrats” are simultaneously committed to conducting cutting-edge research and stewarding the nation’s investment in cancer research, and as a result they have developed an unparalleled expertise. Aviles demonstrates how the interplay of science, politics, and administration shaped the NCI into a mission-oriented agency that enabled significant breakthroughs in cancer research—and in the process, she shows how organizational cultures indelibly stamp scientific work.
1143582073
An Ungovernable Foe: Science and Policy Innovation in the U.S. National Cancer Institute
Winner, 2024 Choice Outstanding Academic Title

In American politics, medical innovation is often considered the domain of the private sector. Yet some of the most significant scientific and health breakthroughs of the past century have emerged from government research institutes. The U.S. National Cancer Institute (NCI) is tasked with both understanding and eradicating cancer—and its researchers have developed a surprising expertise in virus research and vaccine development.

An Ungovernable Foe examines seventy years of federally funded scientific breakthroughs in the laboratories of the NCI to shed new light on how bureaucratic organizations nurture innovation. Natalie B. Aviles analyzes research and policy efforts around the search for a viral cause of leukemia in the 1960s, the discovery of HIV and the development of AIDS drugs in the 1980s, and the invention of the HPV vaccine in the 1990s. She argues that the NCI transformed generations of researchers into innovative public servants who have learned to balance their scientific and bureaucratic missions. These “scientist-bureaucrats” are simultaneously committed to conducting cutting-edge research and stewarding the nation’s investment in cancer research, and as a result they have developed an unparalleled expertise. Aviles demonstrates how the interplay of science, politics, and administration shaped the NCI into a mission-oriented agency that enabled significant breakthroughs in cancer research—and in the process, she shows how organizational cultures indelibly stamp scientific work.
38.0 In Stock
An Ungovernable Foe: Science and Policy Innovation in the U.S. National Cancer Institute

An Ungovernable Foe: Science and Policy Innovation in the U.S. National Cancer Institute

by Natalie B. Aviles
An Ungovernable Foe: Science and Policy Innovation in the U.S. National Cancer Institute

An Ungovernable Foe: Science and Policy Innovation in the U.S. National Cancer Institute

by Natalie B. Aviles

Paperback

$38.00 
  • SHIP THIS ITEM
    In stock. Ships in 3-7 days. Typically arrives in 3 weeks.
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

Winner, 2024 Choice Outstanding Academic Title

In American politics, medical innovation is often considered the domain of the private sector. Yet some of the most significant scientific and health breakthroughs of the past century have emerged from government research institutes. The U.S. National Cancer Institute (NCI) is tasked with both understanding and eradicating cancer—and its researchers have developed a surprising expertise in virus research and vaccine development.

An Ungovernable Foe examines seventy years of federally funded scientific breakthroughs in the laboratories of the NCI to shed new light on how bureaucratic organizations nurture innovation. Natalie B. Aviles analyzes research and policy efforts around the search for a viral cause of leukemia in the 1960s, the discovery of HIV and the development of AIDS drugs in the 1980s, and the invention of the HPV vaccine in the 1990s. She argues that the NCI transformed generations of researchers into innovative public servants who have learned to balance their scientific and bureaucratic missions. These “scientist-bureaucrats” are simultaneously committed to conducting cutting-edge research and stewarding the nation’s investment in cancer research, and as a result they have developed an unparalleled expertise. Aviles demonstrates how the interplay of science, politics, and administration shaped the NCI into a mission-oriented agency that enabled significant breakthroughs in cancer research—and in the process, she shows how organizational cultures indelibly stamp scientific work.

Product Details

ISBN-13: 9780231196697
Publisher: Columbia University Press
Publication date: 01/23/2024
Pages: 360
Product dimensions: 6.12(w) x 9.25(h) x (d)

About the Author

Natalie B. Aviles is an assistant professor of sociology at the University of Virginia.

Table of Contents

Acknowledgments
Introduction
1. Medicine, Meliorism, and the Making of a Modern NCI
2. Cancer Viruses and the Promise of a Vaccine, 1958–1968
3. Moving Targets in the War on Cancer, 1969–1979
4. Back to Basics: Human Cancer Retrovirus Research, 1980–1984
5. HIV Research and Drug Development, 1985–1989
6. Lost in Translation, 1990–2001
7. From Roadmap to Moonshot, 2002–2016
Conclusion
Methodological Appendix
Notes
Bibliography
Index
From the B&N Reads Blog

Customer Reviews